Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 14, 2022

SELL
$19.97 - $25.91 $23.4 Million - $30.4 Million
-1,172,936 Closed
0 $0
Q3 2021

Oct 26, 2021

SELL
$23.99 - $38.59 $278,307 - $447,682
-11,601 Reduced 0.98%
1,172,936 $29.3 Million
Q2 2021

Jul 26, 2021

BUY
$34.94 - $45.35 $1.99 Million - $2.59 Million
57,029 Added 5.06%
1,184,537 $45.7 Million
Q1 2021

Apr 21, 2021

SELL
$32.6 - $37.82 $2.79 Million - $3.24 Million
-85,628 Reduced 7.06%
1,127,508 $39.8 Million
Q4 2020

Jan 22, 2021

BUY
$24.99 - $38.45 $14 Million - $21.5 Million
559,606 Added 85.63%
1,213,136 $46.6 Million
Q3 2020

Oct 08, 2020

SELL
$29.04 - $37.49 $465,859 - $601,414
-16,042 Reduced 2.4%
653,530 $21.5 Million
Q2 2020

Jul 08, 2020

BUY
$20.16 - $34.84 $13.5 Million - $23.3 Million
669,572 New
669,572 $23.3 Million

Others Institutions Holding PETQ

About PetIQ, Inc.


  • Ticker PETQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,312,800
  • Market Cap $908M
  • Description
  • PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medicat...
More about PETQ
Track This Portfolio

Track Riverbridge Partners LLC Portfolio

Follow Riverbridge Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Riverbridge Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Riverbridge Partners LLC with notifications on news.